We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dispute Continues Over Eli Lilly's Reporting of Zyprexa Side Effects
Dispute Continues Over Eli Lilly's Reporting of Zyprexa Side Effects
December 21, 2006
Eli Lilly is countering a published report that claims the company’s internal data showed a higher rate of diabetes in patients taking its antipsychotic medication Zyprexa than documented in the information provided to doctors.